Intestinal absorption of forsythoside A using in situ single-pass intestinal perfusion and in vitro

来源 :中华中医药学会制剂分会、世界中联中药药剂专业委员会2011学术年会暨“龙津杯”中药制剂创新与发展论坛 | 被引量 : 0次 | 上传用户:panxihuanhe
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Forsythoside A (FTA) is the major bioactive component of the extracts from the Forsythiae fructus. The aim of the study is to investigate the absorption mechanism of FTA using Caco-2 cells in vitro and in situ intestinal perfusion model, and to illustrate why the bioavailability orally of FTA was low from the perspectives of absorption. From in situ intestinal perfusion model, the absorption of three different concentrations (2.6、 5.2、 10.4μg·mL-1) of FTA in different intestinal segments was studied with phenol red as the marker. It was shown that the effective permeability coefficient (Peff) of FTA with different concentrations had little significant difference from that obtained after perfusing via duodenum, jejunum and ileum. The Peff of FTA increased obviously after perfusing via duodenum, jejunum and ileum when EDTA(10μg·mL-1), Ciclosporin (10μg·mL-1), Probenecid (200μmol·L-1) and Verapamil (100μg·mL-1), respectively were added to the perfusion fluid, which showed dose-dependence, but Diclophenac Sodium (50μg·mL-1) was opposite.Besides, there was no significant change in the absorption of FTA when Mannitol of different concentrations was added to the perfusion fluid. As shown from in vitro Caco-2 cell model, the apparent permeability coefficients (Papp) of FTA were measured as a function of directions and concentrations. It was demonstrated that the mean of Papp was 4.089× 10-7cm/s in the apical to basolateral (AP-BL) and the efflux ratio was 1.00 approximately over the range of 2.6-10.4μg·mL-1 of FTA from bi-directional transport studies. The transport rate of FTA was dependent on the concentrations. Papp of FTA was not affected by transport directions, different FTA concentrations and SGLT1 inhibitor of different concentrations.In addition, Papp of FTA showed a tendency of increase with the EDTA, Ciclosporin, Probenecid and Verapamil concentrations increasing, but Diclophenac Sodium was opposite. The results above indicated that the absorption of FTA may be passive diffusion and had no difference in different segments of rat intestine. Besides, it was involved paracellular route transport. P-gp, MRPs and OATP may participate in the absorption of FTA in the intestine meanwhile. This observation may demonstrate the possibility that the low permeability of FTA contributes to its low bioavailability orally.
其他文献
由于都市人们长时间伏案工作和上网,再加上工作上的压力和生活节奏的加快,越来越多的都市人患上了所谓的“城市疲劳综合症”。究其原因,多是颈部的交感神经节受到不良刺激引起的,针刀疗法治疗颈椎病见效快、疗效显著、费用相对低廉,值得临床推广。
慢性及过敏性鼻炎在我们的生活中是很常见的一类病,本文对其局部病因病理进行分析,然后根据病变部位及肌群从后枕部肌群开始行针刀治疗,疗效显著。
目的:制备对pH敏感,用于结肠定位的优奇特(Eudragit L100/S100)混合游离膜,并研究其相关特性。方法:采用平面铸膜法,考察成膜湿度、增塑剂的种类与用量及膜材的比例对游离膜的影响;以膜的透湿率、机械性能为指标设计正交实验,优选出最佳的成膜处方。结果:TEC为增塑剂且含量为30%时,膜的机械性能和成模性最好;膜材比例变化对游离膜的机械性能和透湿性影响不大。结论:通过调整增塑剂的种类、用
目的:测定当归浸膏粉和黄芪浸膏粉的等温吸湿曲线及等温吸湿热,并对其吸湿过程进行模型拟合,建立评价中药浸膏粉吸湿性的方法。方法:采用静态法使当归浸膏粉和黄芪浸膏粉处于10%~85%相对湿度范围内,分别测定25℃、35℃、45℃下的吸湿百分率,并以GAB、BET、Henderson、Smith等6个常用吸湿模型进行拟合。利用Clausius-Clapeyron方程计算浸膏粉的等温吸湿热,并拟合25℃、
目的:对柴胡总皂苷提取物进行制剂前研究,为设计合理的剂型提供依据。方法:采用分光光度法和高效液相色谱法研究柴胡总皂苷提取物的溶解度、油水分配系数、稳定性及初步考察了柴胡总皂苷提取物对胃黏膜的刺激性。结果:柴胡总皂苷提取物在水中的溶解度为0.145mg/ml,在pH5.0的缓冲液中,油水分配系数为34.72,在pH9.0的缓冲液中,油水分配系数为60.36,高湿度试验结果不符合规定,刺激性较大。结论
目的:建立大黄三七不同配比时大黄的指纹图谱,以研究二者配比的改变对大黄化学成分的整体影响。方法:采用高效液相色谱法,以甲醇-0.1%磷酸为流动相进行梯度洗脱,检测波长为254nm;以夹角余弦及欧氏距离计算指纹图谱的相似度。结果:建立了大黄三七不同配比时大黄的指纹图谱,两种方法计算的相似度有所不同,以夹角余弦计算的相似度均在0.950以上,以欧氏距离计算的相似度差别较大。结论:大黄三七不同配比对大黄
目的:建立诃子药材的指纹图谱,探讨其与制剂之间的相关性,为其全面质量控制提供参考。方法:采用DiamonsilTM C18色谱柱(4.6mm×250mm,5μm),甲醇-0.5%冰醋酸为流动相,线性梯度洗脱,检测波长为254nm。建立药材的指纹特征图谱,并考察不同干燥工艺中指纹图谱的相关性与变化。结果:建立了诃子药材指纹图谱,药材的指纹图谱与提取物的干燥工艺因素有一定的相关性,但干燥工艺的指纹图谱
目的:研究贝母辛在大鼠体内的药物动力学。方法:液相色谱条件采用C18(3μm,100mm×2.0mm ID),流动相为乙腈-10mmol·L-1(35:65),质谱采用ESI离子源,正离子MRM方式检测。SD大鼠,雌雄各半,单次灌服贝母辛单体,定时采集血样,测定大鼠体内贝母辛的血药浓度,并采用DAS2.0计算其药物动力学参数。结果:在雌、雄大鼠体内,Cmax分别为343.44、413.79μg·L
目的:分析改善和提高中药活性成分生物利用度的方法。方法:以中药蛇床子亲脂性活性成分蛇床子素为对象,综述、分析其生物药剂学和药物动力学特征以及药剂学技术和组分配伍应用对其体内过程及生物利用度的影响。结果:难溶性蛇床子素膜渗透性好,但是生物利用度较低,药剂学技术及组分配伍可改善其体内过程和生物利用度。结论:改善和提高中药活性成分生物利用度不仅可以应用药剂学技术,也可体现在中药复方组分合理配伍之中。
目的:研究醒脑静中环烯醚萜苷类有效成分栀子苷及京尼平龙胆双糖苷大鼠鼻腔吸收特性及相关性。方法:以体积校正法,采用改良的大鼠在体鼻循环模型研究栀子提取物单用、与醒脑静中冰片、麝香分别配伍及醒脑静全方配伍后栀子苷及京尼平龙胆双糖苷大鼠鼻腔吸收。结果:栀子提取物中环烯醚萜苷类代表成分栀子苷和京尼平龙胆双糖苷的大鼠鼻腔吸收符合一级速率过程,为基于浓度梯度的被动吸收。艾片、合成冰片及醒脑静全方配伍可促进栀子